C
azzo
E
et
al
.
192
R
ev
A
ssoc
M
ed
B
ras
2017; 63(2):190-194
factors that generate potential biases and limit the find-
ings. Another systematic review, conducted by Jan et al.,
22
showed favorable results comparable to those of the gen-
eral obese population in relation to weight loss and the
resolution of comorbidities. On the other hand, the au-
thors underscore that the risks are significantly higher,
with 21.3% surgical morbidity, 1.6% perioperative mortal-
ity and 2.4% late-onset mortality. The risk of decompen-
sation of liver function was also high (6.5%) and should
be taken into consideration. The main results of the stud-
ies evaluated are presented in Table 1.
Among severe cirrhotic patients that are candidate to
liver transplant, the choice of technique to be employed
is fundamental due to two key issues: potential damage
to the absorption of immunosuppressive medication and
the possibility of endoscopic access to the biliary tree.
There are no studies examining the pharmacokinetics of
immunosuppressants in liver transplant patients under-
going bariatric surgery. In kidney transplant patients
undergoing gastric bypass, however, there are reports of
a need for larger doses of tacrolimus, sirolimus, myco-
phenolate sodium and cyclosporine.
23
With regard to
access to the biliary tree, stenoses are common after de-
ceased donor transplants, occurring in up to 17% of cases.
24
Due to these factors, vertical sleeve gastrectomy appears
to be the most appropriate technique in this group of
patients, as it does not cause significant malabsorption
and enables endoscopic access to the biliary tree.
The ideal time for bariatric surgery in liver transplant
candidates is another controversial issue. There is a pos-
sibility of performing the procedure before, after and even
during transplantation. A relevant concern in this regard
is the impact of obesity on the outcome of the transplant.
Recent studies have reported that operative mortality,
two-year survival and graft viability are similar in obese
and non-obese individuals. Perioperative morbidity is
slightly higher.
2,3
Performing bariatric surgery in non-
-compensated transplant candidates leads to higher mor-
bidity and mortality, including the occurrence of anasto-
motic fistulas, which often reaches 12.5%.
21,22
Recently, there has been growing interest in the pos-
sibility of endoluminal treatments for obesity in indi-
viduals with high surgical risk. An endoscopic intragastric
balloon implant in this group of patients, which is an
attractive alternative, has presented satisfactory results
in studies conducted by Choudhary et al.
25
A case report by Campsen et al.
26
showed the realiza-
tion of adjustable gastric band implantation during a
liver transplant had satisfactory results after 6 months.
Heimbach et al.
27
reported the combined realization of
liver transplantation and vertical sleeve gastrectomy in
seven patients with one case of a fistula on the staple line
and zero mortality. The combined option is interesting
because it reduces the number of surgical approaches in
high-risk patients. On the other hand, this approach re-
quires complex logistics (especially the concomitant avail-
ability of transplant and bariatric teams) and can combine
serious complications that are not related to either pro-
cedure.
21,22,26,27
Therefore, in patients with non-compen-
sated cirrhosis or with moderate to severe portal hyper-
TABLE 1
Main results of bariatric surgery in individuals with liver diseases.
Study
N Type of study
Surgical technique
Morbidity Perioperative
mortality
Late mortality
Takata et al.
13
15 Retrospective cohort
Vertical sleeve gastrectomy
and gastric bypass
13.3%
0
0
Lin et al.
14
26 Retrospective cohort
Vertical sleeve gastrectomy 23.1%
0
0
Mosko et al.
15
(Compensated cirrhosis)
3,888 Retrospective cohort
Several
NR
0.9%
NR
Mosko et al.
15
(Decompensated cirrhosis)
62 Retrospective cohort
Several
NR
16.3%
NR
Dallal et al.
18
30 Retrospective cohort
Gastric bypass
30%
0
3.3%
Woodford et al.
19
14 Prospectively collected
database analysis
Adjustable gastric band 14.3%
0
0
Shimizu et al.
31
23 Prospective database
analysis
Vertical sleeve gastrectomy
and gastric bypass
34.8%
0
4.3%
Lazzati et al.
21
56 Meta-analysis
Several
23.2%
0
5.3%
Jan et al.
22
122 Meta-analysis
Several
21.3%
1.6%
NR
N: number of patients; NR: not reported.